Communiqués MedCap AB

Actions

Marché Fermé - Nasdaq Stockholm Autres places de cotation 18:00:00 10/07/2026			Varia. 5j.	Varia. 1 janv.
500,50 ^SEK	-1,57%		-8,17%	-8,83%

30/06	SEB relève l'objectif de cours de Medcap à 630 couronnes (590), maintient sa recommandation à l'achat	FW
26/06	Mildef progresse après un contrat, l'indice OMXS30 recule de 0,9 %	FW

26/06	MedCap AB (publ) has signed an agreement to acquire Biopsafe ApS in Denmark.	AQ
05/05	MedCap (Q1 review): Strong EBITA Growth, Poised for Acquisitions	AQ
29/04	MedCap : Presentation Q1 2026	PU
06/03	MedCap : RedEye Serial Acquirers Conference	PU
06/03	MedCap : Danske Bank Small & Midcap Seminar	PU
11/02	MedCap (Q4 review): Beat on Solid Organic Growth	AQ
06/02	MedCap : Year-end Report Q4 2025	PU
06/02	MedCap : Year-end Report Q4 2025 Presentation	PU
07/01	MedCap : SEB Nordic Seminar	PU
27/10/25	MedCap (Q3 review) - Healthy Q3 figures	AQ
24/10/25	Strong organic and acquired growth; EBITA increased by 32%	AQ
01/10/25	Abilia acquires LivAssured	AQ
23/07/25	MedCap Q2 2025 - The rise, fall, and rise again	AQ
23/07/25	Strong quarter with 20 percent EBITA growth and acquisition in Specialty Pharma	AQ
21/07/25	MedCap's Business Area Specialty Pharma Completes the Acquisition of XGX Pharma	AQ
25/06/25	MedCap's Business Area Specialty Pharma Acquires XGX Pharma	AQ
30/04/25	MedCap Q1 2025 - Step by step	AQ
29/04/25	7% growth and EBITA margin recovers to 17%	AQ
03/02/25	MedCap Q4 2024 - A tale of euphoria and despair	AQ
31/01/25	MedCap : Presentation MedCap Q4 2024	PU
31/01/25	Good demand but unsatisfactory earnings. Strong cash flow.	AQ
31/01/25	MedCap's Business Area Assistive Tech Acquires Danrehab	AQ
16/01/25	Preliminary result for the fourth quarter	AQ
04/11/24	Redeye Initiates Coverage of MedCap	AQ
25/10/24	MedCap : Presentation MedCap Q3 2024	PU